CN Patent

CN111432811B — 马来酸曲美布汀的多晶型物及其使用方法

Assigned to Valenta Intellect LLC · Expires 2023-06-23 · 3y expired

What this patent protects

本发明涉及医药、药理学以及化学和制药工业领域，尤其涉及马来酸曲美布汀的新型多晶型物及其生产和使用方法。

USPTO Abstract

本发明涉及医药、药理学以及化学和制药工业领域，尤其涉及马来酸曲美布汀的新型多晶型物及其生产和使用方法。

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN111432811B
Jurisdiction: CN
Classification: —
Expires: 2023-06-23
Drug substance claim: No
Drug product claim: No
Assignee: Valenta Intellect LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.